Moderna (MRNA) closed at $41.95 in the latest trading session, marking a +2.29% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.47%. Meanwhile, the Dow ...

Once one of the biggest winners of the pandemic era, Moderna (MRNA) saw explosive growth as demand for its COVID-19 vaccine ...

As single-stock leveraged ETFs continue to proliferate, Defiance ETFs last week added a 2X Moderna Inc MRNA-linked fund, the Defiance Daily Target 2X Long MRNA ETF MRNX, targeting traders looking for ...

Cramer called the week an extraordinary one, as he pointed out that the Dow Jones Industrial Average crossed 50,000. He recalled that the Dow was around 1,000 when he first walked down the same street ...

We recently published an article titled 11 High Growth Micro-cap Stocks to Buy. On January 6, Citi lowered its price target ...

Eli Lilly to buy Orna Therapeutics, which focuses on ‘in vivo’ CAR-T for autoimmune diseases, for $2.4 billion ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.

Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Ultragenyx Pharmaceutical Inc. between August 3, 2023 and December ...

ACA Pharma granted exclusive rights to register and distribute Omisirge across 15 markets, covering both FDA-approved Omisirge indications DUBLIN, IE / ACCESS Newswire / February 9, 2026 / Ayrmid, Ltd ...

This week's calendar brings a high-volume slate of earnings reports from the technology, consumer discretionary, and energy ...

Investors would keep an eye on profitability, especially after Ford lowered FY25 profit guidance in October following a devastating fire at the Novelis plant—a key aluminum supplier. Wall Street ...

Wall Street EPS/revenue estimates, activist pressure on oil & gas pivot vs renewables, and what to watch in Feb.